Frontera supercomputer aids COVID-19 drug development

By The Science Advisory Board staff writers

March 25, 2020 -- Scientists are urgently working to build the first complete all-atom model of the SARS-CoV-2 coronavirus envelope, estimated to contain over 200 million atoms. This work was conducted as a collaboration between the Amaro Lab of the University of California (UC), San Diego and the National Science Foundation-funded Frontera supercomputer at the University of Texas (UT) at Austin.

Rommie Amaro, PhD, professor of chemistry and biochemistry at UC San Diego, is leading efforts to understand molecular recognition. Most recently, the Amaro Lab used the Frontera supercomputer on March 12-13 to run nanoscale molecular dynamics simulations for the novel coronavirus on up to 4,000 nodes, or about 250,000 of Frontera's processing cores.

This work comes in the wake of the Amaro Lab's recent publication in ACS Central Science on the all-atom simulation of the influenza virus envelope. The work with the two viruses has a number of similarities, according to Amaro.

A SARS-CoV-2 coronavirus envelope all-atom computer model is being developed by the Amaro Lab of UC San Diego on the National Science Foundation-funded Frontera supercomputer of Texas Advanced Computing Center at UT Austin. The image depicts the all-atom influenza virus simulations researchers plan to apply to the novel coronavirus.
A SARS-CoV-2 coronavirus envelope all-atom computer model is being developed by the Amaro Lab of UC San Diego on the National Science Foundation-funded Frontera supercomputer of Texas Advanced Computing Center at UT Austin. The image depicts the all-atom influenza virus simulations (left) researchers plan to apply to the novel coronavirus (right). Image courtesy of Lorenzo Casalino, PhD, (UCSD), Texas Advanced Computing Center.

The simulations will provide insights into the infectivity of SARS-CoV-2. This information will help scientists on the front lines design new drugs and understand how current drugs and new potential drug combinations work.

"Hopefully the public will understand that there are many different components and facets of science to push forward to understand this virus," said Amaro. "These simulations on Frontera are just one of those components, but hopefully an important and a gainful one."


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here